arrow
B

Bülent Polat

University Hospital Wurzburg
H指数:27
被引数:3,898

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term urinary continence and influencing factors after salvage radiotherapy: results of the SAKK 09/10 dose escalation trial

根治性放疗后长期尿失禁及其影响因素:SAKK 09/10剂量递增试验结果

2025-07-080
PRE
Quality of Life After Two Sequences of Total Neoadjuvant Treatment in Patients With Locally Advanced Rectal Cancer in the Randomized CAO/ARO/AIO-12 Phase 2 Trial

CAO/ARO/AIO-12随机对照试验第2阶段中,局部晚期直肠癌患者接受两种序贯总新辅助治疗后生活质量研究

2025-05-210
OAAI
Biomarkers in prostate cancer: current status and future directions in radiotherapy-statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)

前列腺癌中的生物标志物:放射治疗领域的现状与未来方向——德国放射肿瘤学会(DEGRO)前列腺癌工作组声明

2025-03-250
OA
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

预测前列腺癌放疗剂量反应:NRG/RTOG 0126和SAKK 09/10随机III期试验中辐射特征验证

2025-02-010
OAAI
Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials

接受全直肠系膜切除术或选择性观察等待策略治疗的总新辅助治疗患者的生存情况:CAO/ARO/AIO-12和OPRA随机II期试验的合并分析

2025-01-012
PRE
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy- an ancillary study of the SAKK 09/10 randomized clinical trial

在根治性前列腺切除术后接受挽救性放疗而无激素治疗的患者中验证Decipher基因组分类器-SAKK 09/10随机临床试验的辅助研究

2022-09-0128
OA
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial
2022-05-015
OAAI
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial

剂量强化与常规剂量挽救性放疗治疗前列腺切除术后生化复发前列腺癌: SAKK 09/10随机3期试验

2021-09-0171
PREAI
Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database
2021-06-0139
OAAI
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial
2021-02-0111
PREAI